AVEO Aveo Pharmaceuticals Inc

AVEO Pharmaceuticals Inc is a biopharmaceutical company focused on discovering, developing and commercializing novel cancer therapeutics.

$7.80  -0.01 (-0.13%)
As of 09/27/2022 16:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  03/12/2010
Outstanding shares:  34,614,284
Average volume:  263,233
Market cap:   $270,337,558
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Valuation   (See tab for details)
PE ratio:   -6.48
PB ratio:   7.23
PS ratio:   7.69
Return on equity:   -112.12%
Net income %:   -117.85%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy